Menu

Filters

  • Result Found In

We are your partner in helping you for the upcoming respiratory virus season

We are your partner in helping you for the upcoming respiratory virus season

We are your partner in helping you for the upcoming respiratory virus season

Get your test kits and vaccines for respiratory season to help protect your community.

Every year, respiratory viruses affect millions in the United States. Respiratory viruses in the United States are increasing in many regions to begin the new year, as well as visits to emergency rooms.¹


It is imperative to ensure that your patients stay healthy year round.

From test kits for COVID-19, RSV, and flu to essential vaccines, we deliver the tools you need to navigate the respiratory virus season with confidence. Advantages to getting these tools from Henry Schein includes:

Broad offerings from top brands
99% historical fulfillment rate
99.91% order accuracy

See our portfolio of respiratory season test kits today. We offer top brands, including:

Abbott
BD
Sekisui
Quidel

Flu

  • Reader

  • Molecular

  • Lateral Flow

RSV

  • Reader

  • Molecular

  • Lateral Flow

Multi Assay

  • Reader

  • Molecular

  • Lateral Flow

COVID-19

  • Reader

  • Molecular

  • Lateral Flow


See our portfolio of COVID-19, RSV and flu vaccines today:

Our vaccine portfolio is updated based on availability. Please check back regularly for the latest information.


¹ABC, Viruses rising in US as peak season arrives; here's what to know
*The Moderna COVID-19 Vaccine (2024-2025 Formula) has not been approved or licensed by FDA, but has been authorized for emergency use by the FDA, under an Emergency Use Authorization (“EUA”) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months through 11 years of age.
*The Pfizer-BioNTech COVID-19 Vaccine, Monovalent has not been approved or licensed by the FDA, but has been authorized for emergency use by the FDA, under an Emergency Use Authorization (“EUA”) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals aged 6 months of age and older.
*The Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 Formula) has not been approved or licensed by the FDA, but has been authorized for emergency use by the FDA, under an Emergency Use Authorization (“EUA”) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 12 years of age and older.